**Question:** Pneumopathy is a side effect of all EXCEPT:

A. Streptococcus pneumoniae
B. Methotrexate
C. Aspirin
D. Penicillin

**Core Concept:** Pneumopathy refers to the inflammation or damage to the lung parenchyma, which can occur due to various factors. Side effects of medications are one such cause. Pneumopathy can be classified as obstructive or restrictive, based on lung function tests.

**Why the Correct Answer is Right:** Methotrexate is an immunosuppressive agent used in cancer chemotherapy, rheumatoid arthritis, and psoriasis treatment. Its side effects can include pulmonary toxicity, which presents as pneumopathy. Streptococcus pneumoniae is a common bacterial pathogen causing pneumonia, and aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that can lead to aspiration pneumonia. Penicillin is a beta-lactam antibiotic and is generally well-tolerated with minimal pulmonary toxicity.

**Why Each Wrong Option is Incorrect:**

A. Streptococcus pneumoniae is the causative agent of pneumonia and can directly invade the lung parenchyma, leading to pneumopathy. Therefore, it is not a suitable answer.

B. Methotrexate is a well-known medication causing pulmonary toxicity. While it is true that some patients may develop pneumopathy, the question specifically asks for a medication that is "not" associated with pneumopathy.

C. Aspirin is a common NSAID used to relieve pain, inflammation, and fever. Aspirin can cause aspiration pneumonia, which may present as pneumopathy. However, it does not specifically address the question of medications "not" associated with pneumopathy.

D. Penicillin is a beta-lactam antibiotic widely used to treat bacterial infections. Although some patients may experience mild side effects such as skin rash, it is not a medication that typically causes pneumopathy.

**Clinical Pearl:**

Understanding the potential side effects of medications is crucial for prescribers and patients alike. Always ensure that the benefits outweigh the risks, especially when prescribing medications with known pulmonary toxicity. In addition, educate patients about the signs and symptoms of medication-induced pneumopathy, so they can promptly report any respiratory symptoms to the healthcare provider for appropriate management.